UA70016U - Method for correction of melatonin-forming epiphysis function in patients with hypertension - Google Patents

Method for correction of melatonin-forming epiphysis function in patients with hypertension

Info

Publication number
UA70016U
UA70016U UAU201112987U UAU201112987U UA70016U UA 70016 U UA70016 U UA 70016U UA U201112987 U UAU201112987 U UA U201112987U UA U201112987 U UAU201112987 U UA U201112987U UA 70016 U UA70016 U UA 70016U
Authority
UA
Ukraine
Prior art keywords
melatonin
epiphysis
forming
function
patients
Prior art date
Application number
UAU201112987U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Вадим Александрович Ищук
Валерий Брониславович Шатило
Елена Владимировна Бондаренко
Иванна Анатолиевна Антонюк-Щеглова
Original Assignee
Государственное Учреждение "Институт Геронтологии Им. Д.Ф. Чеботарева" Намн Украины
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное Учреждение "Институт Геронтологии Им. Д.Ф. Чеботарева" Намн Украины filed Critical Государственное Учреждение "Институт Геронтологии Им. Д.Ф. Чеботарева" Намн Украины
Priority to UAU201112987U priority Critical patent/UA70016U/en
Publication of UA70016U publication Critical patent/UA70016U/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A method for correction of melatonin-forming epiphysis function in patients with hypertension comprises the daily blood pressure monitoring. Additionally, the average daily systolic blood pressure and diurnal index of average systolic blood pressure are determined and state of melatonin-forming epiphysis function is calculated by the formula and at values of melatonin-forming epiphysis function below the age norm - 9 µg - melatonin is administered at a dose of 3 mg at 9-00 p.m.
UAU201112987U 2011-11-04 2011-11-04 Method for correction of melatonin-forming epiphysis function in patients with hypertension UA70016U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201112987U UA70016U (en) 2011-11-04 2011-11-04 Method for correction of melatonin-forming epiphysis function in patients with hypertension

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201112987U UA70016U (en) 2011-11-04 2011-11-04 Method for correction of melatonin-forming epiphysis function in patients with hypertension

Publications (1)

Publication Number Publication Date
UA70016U true UA70016U (en) 2012-05-25

Family

ID=52280944

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201112987U UA70016U (en) 2011-11-04 2011-11-04 Method for correction of melatonin-forming epiphysis function in patients with hypertension

Country Status (1)

Country Link
UA (1) UA70016U (en)

Similar Documents

Publication Publication Date Title
NZ589445A (en) Rasagiline for parkinson's disease modification
GEP201706719B (en) Pirfenidone treatment for patients with atypical liver function
MY175997A (en) Antl-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig protein scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition
MX2011009804A (en) A dose of ave5026 for the treatment of venous thromboembolism in patients with severe renal impairment.
UA70016U (en) Method for correction of melatonin-forming epiphysis function in patients with hypertension
UA35015U (en) Method for immunorehabilitation of patients with metabolic syndrome
UA51456U (en) Method for complex treatment of early forms of syphilis
UA35558U (en) Method for treating candidiasis of oral mucosa in patients with diabetes mellitus
UA44831U (en) Method for treating female patients with hypertension and diabetes mellitus type ii
UA51089U (en) Method for correcting nephropathy in setting of arterial hypertension in experiment
UA45512U (en) Method for treating arterial hypertension in aged patients
UA55466U (en) Method for treating metabolic disorders in patients with contusion trauma of eye
UA55818U (en) Method for treating chronic diseases of cornea
UA49534U (en) Method for optimizing treatment of heart failure in aged patients after myocardial infarction
UA59658U (en) method for treating patients with the syndrome of increased fatigue with chronic diseases of the hepatobiliary system
UA76558U (en) method for treating gastroesophageal reflux disease in patients with type 2 diabetes
UA59668U (en) method for the correction of the cytokine profile of blood of patients with varicose veins in the leg during inter-relapse of erysipelas
UA53527U (en) Method for complex treatment of chronic heart failure in aged patients with ischemic heart disease
UA69733U (en) Method for diagnostics of diastolic dysfunction of left ventricle in patients with uncomplicated hypertonic disease
UA54839U (en) Method for treating psoriasis
UA59444U (en) Method for selecting hypolipidemic therapy in female patients with metabolic syndrome aged over 50
UA59186U (en) method for complex treatment of patients with renal parenchimal arterial hypertension taking into account genotype in the background of chronic pyelonephritis
UA49567U (en) method for treatment of chronic diseases of intestines in patients with hypertonY
UA34796U (en) Method for correcting state of macrophage-phagocyte system in patients with syndrome of increased fatigue
UA59667U (en) method for medical rehabilitation of patients with nonalcoholic steatohepatitis using antihomotoxic treatment agents